Jan 8 |
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
|
Jan 5 |
Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
|
Jan 2 |
Aditxt regains compliance with Nasdaq rule on minimum stockholders' equity
|
Jan 2 |
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
|
Dec 13 |
Aditxt, Occidental Petroleum, Cava Group, Adobe, Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
Dec 12 |
Why Is Life Sciences-Focused Aditxt Stock Trading Higher Today?
|
Dec 12 |
Aditxt to acquire women’s health company Evofem Biosciences
|
Dec 12 |
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
|
Nov 30 |
What's Going On With Aditxt Inc Stock?
|
Nov 30 |
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|